650
Participants
Start Date
January 28, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
July 31, 2029
Ficerafusp alfa
Investigational
Pembrolizumab (KEYTRUDA®)
Immunotherapy agent used in combination with investigational agent
Placebo
Placebo Control
RECRUITING
Site#0302, Camperdown
RECRUITING
Site#0304, Waratah
RECRUITING
Site #0306, Kingswood
RECRUITING
Site#0402, Rotorua
RECRUITING
Site#0301, North Melbourne
RECRUITING
Site #0303, Heidelberg
RECRUITING
Site #0305, Southport
RECRUITING
Site#0307, Tugun
RECRUITING
Site#0308, Murdoch
RECRUITING
Site #0401, Christchurch
RECRUITING
Site#0142, New York
RECRUITING
Site #0103, Pittsburgh
RECRUITING
Site #0123, Pittsburgh
RECRUITING
Site#0127, Newark
RECRUITING
Site #0112, Baltimore
RECRUITING
Site#0134, Charlottesville
RECRUITING
Site #0129, Richmond
RECRUITING
Site#0118, Durham
RECRUITING
Site#0104, Charleston
RECRUITING
Site #0136, Palm Bay
RECRUITING
Site #0105, Tampa
RECRUITING
Site # 0137, Birmingham
RECRUITING
Site#0126, Nashville
RECRUITING
Site#0111, Louisville
RECRUITING
Site#0115, Louisville
RECRUITING
Site#0109, Lexington
RECRUITING
Site #0151, Cleveland
RECRUITING
Site #0108, Cleveland
RECRUITING
Site#0154, Canton
RECRUITING
Site#0117, Cincinnati
RECRUITING
Site#0140, Iowa City
RECRUITING
Site #0133, Chicago
RECRUITING
Site #0149, Westwood
RECRUITING
Site#0102, Houston
RECRUITING
Site #0122, Aurora
RECRUITING
Site #0124, Aurora
RECRUITING
Site#0121, Aurora
RECRUITING
Site #0106, Los Angeles
RECRUITING
Site #0107, La Jolla
RECRUITING
Site #0150, Stanford
RECRUITING
Site#0144, Sacramento
RECRUITING
Site #0113, Portland
RECRUITING
Site #0125, Seattle
RECRUITING
Site#0120, Vancouver
RECRUITING
Site #0131, Boston
RECRUITING
Site#0101, Boston
RECRUITING
Site #0119, Hackensack
RECRUITING
Site #0132, Providence
RECRUITING
Site #0202, Vancouver
RECRUITING
Site #0203, Montreal
RECRUITING
Site #0505, London
RECRUITING
Site # 0501, Sutton
Lead Sponsor
Bicara Therapeutics
INDUSTRY